Reference
Armand P, et al. Outcomes of allogeneic hematopoietic stem cell transplantation (HSCT) after treatment with nivolumab for re lapsed/refractory hodgkin lymphoma. Blood 128: No. 22, 2 Dec 2016. Available from: URL: http://www.bloodjournal.org/content/128/22/3502 [abstract] - USA
Rights and permissions
About this article
Cite this article
Nivolumab. Reactions Weekly 1640, 275 (2017). https://doi.org/10.1007/s40278-017-26828-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-26828-6